The United States may have reached a turning point in its decades-long battle against obesity. Recent data suggests that 2020 ...

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.

The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Senators grilled the top executive of Novo Nordisk over why the Danish company charges Americans far more for the blockbuster weight-loss drug Wegovy and diabetes drug Ozempic than it does ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says his company is working to expand manufacturing to meet the supply ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Read the latest Collecties Wegovy Ozempic news for entrepreneurs and small businesses from Inc. See related articles, photos, ...